EASTERN COOPERATIVE ONCOLOGY GROUP

罗切斯特大学癌症中心（URCC）是一个健康和 作为多医院联合体组织的研究所 涉及五家提供全方位服务的社区医院。 URCC是 致力于临床和基础实验室研究，病人护理， 和教育 五个国家的所有执业肿瘤学家 医院必须，而且确实，同时举行至少两个主要的 预约-一个在癌症中心，一个在大学 部门-并受双方的政策和程序 中心和部门。 表演场地还包括我们的 加拿大魁北克市的加拿大外展卫星和一个财团 纽约州北部的CCOP设施。 我们非常适合参加东部合作组织 肿瘤组治疗试验、癌症控制研究和其他 科学研究活动。 继续保持成员资格将使 我们带来的好处，有前途的临床研究， 癌症社区，加速癌症治疗的进步， 通过快速收集数据传播信息 和出版物，并提高护理和治疗水平 希望能提高存活时间和生活质量， 我们的癌症患者。 来自ECOG研究的数据和信息 项目在区域、国家和国际各级提出， 罗切斯特ECOG研究者的会议。 对这个项目很重要的是，癌症中心的研究人员 和工作人员提供了一个强有力的联系， 概念，如化疗和放射增敏剂， 保护剂，IL-2/LAK细胞研究，化学预防研究，光- 动态治疗、肿瘤细胞疫苗和淋巴因子研究。 URCC对癌症有着长期的兴趣和经验 控制研究，并将提供专业知识，这一扩大领域 在ECOG中的研究。 主要人员是主席或 担任许多ECOG模式、疾病 定向和行政委员会。 URCC是手指湖唯一的癌症设施 卫生区面积120万人，人口120万人。

The University of Rochester Cancer Center (URCC) is a health and research institute organized as a multihospital consortium involving five full-service community hospitals. The URCC is committed to clinical and basic laboratory research, patient care, and education. All practicing oncologists in each of the five hospitals must, and do, hold at least two simultaneous primary appointments - one in the Cancer Center and one in a University department - and are subject to the policies and procedures of both the Center and the department. Performance sites also include our Canadian outreach satillite in Quebec City, Canada and a consortium CCOP facility in upstate NY. We are ideally suited to participate in the Eastern Cooperative Oncology Group treatment trials, cancer control studies, and other scientific research activities. Continued membership will enable us to bring the benefits of promising clinical investigations to the cancer community, accelerate the advances in cancer therapy, provide dissemination of information through rapid data collection and publications, and to improve the level of care and treatment to hopefully enhance the length of survival and quality of life in our cancer patients. Data and information from ECOG research projects are presented at regional, national and international meetings and conferences by the Rochester ECOG investigators. Important to this program is that the Cancer Center investigators and staff provide a strong link between laboratory research concepts, such as chemotherapy and radiation sensitizers and protectors, IL-2/LAK cell studies, chemoprevention studies, photo- dynamic therapy, tumor cell vaccine and lymphokine research. The URCC has a longstanding interest and experience in cancer control studies and will provide expertise to this expanded area of research within the ECOG. Key personnel are chairpersons or serve on steering committees of many of the ECOG modality, disease oriented and administrative committees. The URCC is the only cancer facility serving the Finger Lakes Health Region area, with a population of 1.2 million people.